同步细针穿刺与粗针活检用于实体瘤二代测序的对比研究
该研究对比了同步获取的细针穿刺(FNA)与粗针活检(CNB)样本用于实体瘤二代测序的性能。在24对样本中,CNB检出的所有体细胞突变在FNA中均被检出;FNA涂片的肿瘤分数显著更高(P=0.003),但DNA产量显著更低(P=0.01);FNA的标准化平均扩增子覆盖度更高、失败扩增子更少、突变等位基因频率更高。另对100对样本分析显示FNA的总体细胞量和肿瘤分数均显著高于同步CNB(P<0.001)。结论认为细胞学标本应更好地整合入常规分子诊断流程。
要点
- 同步FNA与CNB样本中,CNB检出的所有体细胞突变在FNA中均被检出。
- FNA涂片肿瘤分数显著高于CNB(P=0.003),但DNA产量显著低于CNB(P=0.01)。
- FNA的测序指标更优:扩增子覆盖度更高、失败扩增子更少、突变等位基因频率更高。
核心结论
- FNA样本通常比同步获取的CNB样本提供更好的细胞量、更高的肿瘤分数和更优的测序指标。
研究设计与样本
- 回顾性对比研究,纳入同步获取的FNA与CNB样本24对进行二代测序比较,另纳入100对恶性样本评估总体细胞量和肿瘤分数。
主要发现
- CNB检出的所有体细胞突变在配对FNA中均被检出。
- FNA涂片肿瘤分数显著高于CNB(P=0.003)。
- FNA涂片总体DNA产量显著低于CNB(P=0.01)。
- FNA的标准化平均扩增子覆盖度显著高于配对CNB,失败扩增子数更少,总体突变等位基因频率更高。
- 100对样本中FNA的总体细胞量和肿瘤分数均显著高于同步CNB(P<0.001)。
临床怎么用
- 细胞学标本应更好地整合入常规分子诊断流程,以最大化利用有限组织进行临床相关基因组检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Minimally invasive procedures, such as fine needle aspiration and core needle biopsy, are commonly used for the diagnosis in solid organ malignancies. In the era of targeted therapy, it is crucial for molecular testing to be performed on these limited volume specimens. Although several recent studies have demonstrated the utility of small biopsy specimens for molecular testing, there remains debate as to whether core needle biopsy specimens are more reliable than fine needle aspiration for molecular studies. In this study, we reviewed concurrently acquired fine needle aspiration and core needle biopsy samples (n=24), and compared overall cellularity, tumor fraction, and the results of next-generation sequencing. All somatic mutations detected in core needle biopsy samples were also detected in fine needle aspiration samples. The estimated tumor fraction was significantly higher in fine needle aspiration smears than core needle biopsy samples (P=0.003), whereas the overall DNA yield from smears was significantly lower than that obtained from the core needle biopsy specimens (P=0.01). The normalized average amplicon coverage for the genes analyzed was significantly higher in cytology smears than paired core needle biopsy samples, with lower numbers of failed amplicons and higher overall mutation allelic frequencies seen in the former. We further evaluated 100 malignant fine needle aspiration and core needle biopsy samples, acquired concurrently, for overall cellularity and tumor fraction. Overall cellularity and tumor fraction of fine needle aspiration samples was significantly higher than concurrently acquired core needle biopsy samples (P<0.001). In conclusion, we show that fine needle aspiration samples frequently provide better cellularity, higher tumor fraction, and superior sequencing metrics than concurrently acquired core needle biopsy samples. Cytologic specimens, therefore, should be better integrated into routine molecular diagnostics workflow to maximize limited tissues for clinically relevant genomic testing.
引用
- Roy-Chowdhuri S, Chen H, Singh RR, et al. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. Mod Pathol. 2017. PMID: 28084342. doi:10.1038/modpathol.2016.228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。